Huang Po, Li Bo, Feng Shuo, Guo Yuhong, Zhao Guozhen, Wang Dongdong, Liu Qingquan
Department of Emergency Medicine, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Clinical Medical College of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China.
Ann Transl Med. 2019 Mar;7(6):112. doi: 10.21037/atm.2018.12.22.
To evaluate the efficacy and safety of Xuebijing injection (XBJ) treatment for acute organophosphorus pesticide poisoning.
Using the PubMed, Cochrane, Embase, Sinomed, Wanfang, CNKI, and Weipu (VIP) databases from the beginning of the datasets until December 2017, all of the relevant randomized controlled trials were identified. Relative risks (RR), weighted mean difference (WMD), along with 95% confidence interval (95% CI) were used to analyze the main outcomes. Statistical analysis was performed using the RevMan software version 5.3. The qualities of the involved studies were assessed by the risk of bias according to the Cochrane handbook.
Twenty-six randomized controlled trials with 1,880 participants were collected in total. Compared with just conventional therapy alone, XBJ combined with conventional therapy significantly reduced the 7-day mortality rate (RR: 0.33; 95% CI: 0.22-0.49), CRP in the 50 mL group (WMD: -11.60; 95% CI: -14.38 to -8.83), CRP in the 100 mL group (WMD: -1.73; 95% CI: -2.91 to -0.55), AChE in the 50 mL group (WMD: -4.58;95% CI: -5.87 to -3.28), AChE in the 100 mL group (WMD: -1.73; 95% CI: -2.07 to -1.39), hospital stays in the 50 mL group (WMD: -4.26; 95% CI: -4.89 to -3.64), TNF-α in the 50 mL group (WMD: -2.66; 95% CI: -4.99 to -0.32), NF-κB in the 50 mL group (WMD: -13.07; 95% CI: -14.67 to -11.47), and CK-MB in the 50 mL group (WMD: -32.28; 95% CI: -40.62 to -23.93). However, there was no statistical difference of TNF-α in the 100 mL group (WMD: -2.17; 95% CI: -4.66 to 0.32).
XBJ has a significant clinical efficacy for the treatment of patients with acute organophosphorus pesticide poisoning. The most effective dose is 50 mL, while the most effective frequency is twice a day. However, more studies are needed to confirm the extract efficacy of XBJ.
评估血必净注射液(XBJ)治疗急性有机磷农药中毒的疗效和安全性。
检索PubMed、Cochrane、Embase、中国生物医学文献数据库、万方数据库、中国知网和维普数据库,收集从各数据库建库起始至2017年12月的所有相关随机对照试验。采用相对危险度(RR)、加权均数差(WMD)及95%置信区间(95%CI)分析主要结局指标。使用RevMan 5.3软件进行统计分析。根据Cochrane手册,通过偏倚风险评估所纳入研究的质量。
共纳入26项随机对照试验,1880例参与者。与单纯常规治疗相比,XBJ联合常规治疗显著降低了7天死亡率(RR:0.33;95%CI:0.22 - 0.49)、50 mL组的CRP(WMD:-11.60;95%CI:-14.38至-8.83)、100 mL组的CRP(WMD:-1.73;95%CI:-2.91至-0.55)、50 mL组的AChE(WMD:-4.58;95%CI:-5.87至-3.28)、100 mL组的AChE(WMD:-1.73;95%CI:-2.07至-1.39)、50 mL组的住院时间(WMD:-4.26;95%CI:-4.89至-3.64)、50 mL组的TNF-α(WMD:-2.66;95%CI:-4.99至-0.32)、50 mL组的NF-κB(WMD:-13.07;95%CI:-14.67至-11.47)以及50 mL组的CK-MB(WMD:-32.28;95%CI:-40.62至-23.93)。然而,100 mL组的TNF-α差异无统计学意义(WMD:-2.17;95%CI:-4.66至0.32)。
XBJ治疗急性有机磷农药中毒患者具有显著临床疗效。最有效剂量为50 mL,最有效频次为每日两次。然而,需要更多研究来证实XBJ的确切疗效。